Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2Unspecified Adult Solid Tumor, Protocol Specific 1Teratoma 1Neoplasms, Germ Cell and Embryonal 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1

Interventions

Etoposide 18Cisplatin 16Ifosfamide 14Carboplatin 14Filgrastim 12Bleomycin 12Peripheral Blood Stem Cell Transplantation 9Paclitaxel 9Radiotherapy 6etoposide phosphate 5Thiotepa 5Granulocyte Colony-Stimulating Factor 5Cyclophosphamide 4pegfilgrastim 3Mesna 3Magnetic Resonance Spectroscopy 3liposomal amphotericin B 2ixabepilone 2Vinblastine 2Therapeutics 2Temozolomide 2Specimen Handling 2Oxaliplatin 2Neoadjuvant Therapy 2Immunohistochemistry 2Chemotherapy, Adjuvant 2Amifostine 2sodium thiosulfate 1sargramostim 1ribociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Teratoma × Respiratory Physiological Phenomena × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡